Webinars

Webinars

We have a selection of fasincating webinars for you to view. 

Webinar, Reagents

Anti-Idiotype Monoclonal Antibodies

Join Dr. Stephen Pelsue, Science Director at BBI Solutions (formerly Maine Biotechnology Services), in our webinar focused on the development of anti-idiotype (anti-id) antibodies. Anti-id monoclonal ...

Webinar, Reagents

Selecting Antibodies for Infectious Disease Immunoassays

Presented by our in-house antibody development expert Dr Stephen Pelsue. The webinar focuses on immunoassay detection of infectious diseases and some of the key antibody characteristics for the develo...

Webinar, Reagents

Characteristics of Gold Nanoparticles for Immunoconjugation

We are pleased to bring you our first webinar in our new series 'Lateral flow assay development - key fundamentals when considering your outsourcing partner'. Our in-house experts Nikki Robins...

Webinar, Digital

How are mobile medical apps regulated?

Understanding the regulation of mobile apps with a medical purpose is essential, as the future of healthcare shifts towards decentralised point of care testing (POCT). View our webinar recording and l...

Webinar, Digital, Archive

Novarum - Reading lateral flow tests with mobile

In the meantime you can view the previously recorded Novarum webinar via the link. The challenges of Point of Care Tests (POCT) to interpret data, limits the technology to laboratory use. Yet, the con...

Webinar, Digital

The Mobile Diagnostic Journey

We are pleased to bring you our latest webinar in which we explore The Mobile Diagnostic Journey BBI Solutions Novarum technology transforms a smartphone into a diagnostic test reader, empowering user...

Webinar, Digital

How are mobile medical apps regulated?

Understanding the regulation of mobile apps with a medical purpose is essential, as the future of healthcare shifts towards decentralised point of care testing (POCT). View our webinar recording and l...

Webinar, Digital, Archive

Novarum - Reading lateral flow tests with mobile

In the meantime you can view the previously recorded Novarum webinar via the link. The challenges of Point of Care Tests (POCT) to interpret data, limits the technology to laboratory use. Yet, the con...

Webinar, Digital

The Mobile Diagnostic Journey

We are pleased to bring you our latest webinar in which we explore The Mobile Diagnostic Journey BBI Solutions Novarum technology transforms a smartphone into a diagnostic test reader, empowering user...

Webinar, Reagents

Anti-Idiotype Monoclonal Antibodies

Join Dr. Stephen Pelsue, Science Director at BBI Solutions (formerly Maine Biotechnology Services), in our webinar focused on the development of anti-idiotype (anti-id) antibodies. Anti-id monoclonal ...

Webinar, Reagents

Selecting Antibodies for Infectious Disease Immunoassays

Presented by our in-house antibody development expert Dr Stephen Pelsue. The webinar focuses on immunoassay detection of infectious diseases and some of the key antibody characteristics for the develo...

Webinar, Reagents

Characteristics of Gold Nanoparticles for Immunoconjugation

We are pleased to bring you our first webinar in our new series 'Lateral flow assay development - key fundamentals when considering your outsourcing partner'. Our in-house experts Nikki Robins...

No webinars found

Webinar, Digital, Archive

Novarum - Reading lateral flow tests with mobile

In the meantime you can view the previously recorded Novarum webinar via the link. The challenges of Point of Care Tests (POCT) to interpret data, limits the technology to laboratory use. Yet, the con...

BBI Solutions Brands

diarect.png

The acquisition of DIARECT in June 2020 and their world leading recombinant autoimmune antigen capability immediately enhances BBI’s portfolio and position as a ‘complete’ immunoassay reagent supplier. This further enhances BBI’s position as the world’s largest diagnostics components company with a market leading antigen portfolio.

mbs.png

Maine Biotechnology Services brings 27 years of knowledge, experience, process development, and project management to our customers to ensure the best possible antibodies for any application. As antibody development goals in the biotechnology and pharmaceutical industry have evolved the acquisition of MBS will help BBI further meet and exceed our customers needs.

Newsletter

Signup for our newsletter to receive the latest BBI Solutions updates and special offers in your inbox